683 Capital Management, LLC
13F Reported Value
ⓘ$2.0B
incl. option notional
Equity Holdings
ⓘ$1.1B
Option Notional
ⓘ$949.0M
$929.6M puts / $19.4M calls
Holdings
153
Latest Filing
2026-06-30
Filing Quarter
Q2 2026
Portfolio Overview
683 Capital Management, LLC disclosed 153 positions worth $2.0B in its Form 13F-HR for Q2 2026 — $1.1B in common stock plus $949.0M of put/call option positions (reported at underlying notional value, not premium at risk), led by $PLTR (Palantir Technologies Inc.) puts, followed by $LLY and $NVDA. During the quarter the fund opened 21 new positions and exited 103 and a full exit from $TSLA. The portfolio is most concentrated in Healthcare (48.2% of disclosed assets). All figures are sourced directly from 683 Capital Management, LLC’s Form 13F-HR filing with the SEC under CIK 1404574.
AI Fund Analysis
ConcentratingSector Allocation
AUM History
Top Equity Holdings by Value
Option Positions
13F rules report options at the value of the underlying shares (notional) — not the premium paid or capital at risk. Shown separately from the equity sleeve above.
Quarterly Activity — Q2 2026
Click any card to unlockTop Holdings
- 84.6#7
Quality
$283.4M2,428,700 sh - 87.5#2
Quality
$184.7M154,000 sh - 85.9#5
Quality
$91.2M456,000 sh SPDR SERIES TRUST - ST STR SP BIOT PUT
—Quality
$85.5M540,000 sh- 62.4
Quality
$73.2M365,000 sh - 72.6
Quality
$61.7M245,000 sh - 71.6
Quality
$49.4M750,000 sh - 40.7
Quality
$48.3M90,000 sh - 48.4
Quality
$44.6M660,000 sh - —
Quality
$40.7M470,000 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 Palantir Technologies Inc.$PLTRPUT | 84.6#7 | $283.4M | 2,428,700 |
 ELI LILLY & Co$LLYPUT | 87.5#2 | $184.7M | 154,000 |
 NVIDIA CORP$NVDAPUT | 85.9#5 | $91.2M | 456,000 |
| SPDR SERIES TRUST - ST STR SP BIOT PUT | — | $85.5M | 540,000 |
 CAPITAL ONE FINANCIAL CORP$COF | 62.4 | $73.2M | 365,000 |
 AbbVie Inc.$ABBVPUT | 72.6 | $61.7M | 245,000 |
 CARVANA CO.$CVNA | 71.6 | $49.4M | 750,000 |
 MADRIGAL PHARMACEUTICALS, INC.$MDGLPUT | 40.7 | $48.3M | 90,000 |
 ANAPTYSBIO, INC$ANAB | 48.4 | $44.6M | 660,000 |
 Joint Stock Co Kaspi.kz$KSPI | — | $40.7M | 470,000 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of 683 Capital Management, LLC's 153 positions.
Showing top 10 of 153 holdings.
Sector Allocation
Healthcare
$524.0M
Consumer Discretionary
$143.8M
Financials
$135.4M
Industrials
$121.3M
Technology
$59.1M
Materials
$45.2M
Real Estate
$16.8M
Energy
$15.6M
Top Holdings — 683 Capital Management, LLC (Q2 2026)
Top 150 of 153 disclosed positions (by reported value) from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $PLTRPUT | Palantir Technologies Inc. | $283.4M | — | +4% | 84.6 |
| 2 | $LLYPUT | ELI LILLY & Co | $184.7M | — | +15% | 87.5 |
| 3 | $NVDAPUT | NVIDIA CORP | $91.2M | — | +0% | 85.9 |
| 4 | — | SPDR SERIES TRUST - ST STR SP BIOT | $85.5M | — | NEW | — |
| 5 | $COF | CAPITAL ONE FINANCIAL CORP | $73.2M | 6.7% | -3% | 62.4 |
| 6 | $ABBVPUT | AbbVie Inc. | $61.7M | — | NEW | 72.6 |
| 7 | $CVNA | CARVANA CO. | $49.4M | 4.5% | +384% | 71.6 |
| 8 | $MDGLPUT | MADRIGAL PHARMACEUTICALS, INC. | $48.3M | — | +0% | 40.7 |
| 9 | $ANAB | ANAPTYSBIO, INC | $44.6M | 4.1% | +6% | 48.4 |
| 10 | $KSPI | Joint Stock Co Kaspi.kz | $40.7M | 3.7% | -1% | — |
| 11 |  $BBIO | BridgeBio Pharma, Inc. | $38.8M | 3.6% | +0% | 36.9 |
| 12 |  $BDX | BECTON DICKINSON & CO | $37.8M | 3.5% | +11% | 59 |
| 13 |  $MOH | MOLINA HEALTHCARE, INC. | $37.7M | 3.5% | +3% | 56.5 |
| 14 |  $PRAXPUT | Praxis Precision Medicines, Inc. | $37.0M | — | -2% | — |
| 15 |  $HGV | Hilton Grand Vacations Inc. | $36.1M | 3.3% | -11% | 56.1 |
| 16 |  $PTGX | Protagonist Therapeutics, Inc | $35.5M | 3.3% | -18% | 59.4 |
| 17 |  $ALNYPUT | ALNYLAM PHARMACEUTICALS, INC. | $32.4M | — | -16% | 71.4 |
| 18 | — | ARK ETF TR - GENOMIC REV ETF | $31.5M | — | +114% | — |
| 19 |  $MGTX | MeiraGTx Holdings plc | $31.1M | 2.9% | -6% | — |
| 20 |  $WVE | Wave Life Sciences, Inc. | $28.8M | 2.6% | +1% | 7.5 |
| 21 |  $QURE | uniQure N.V. | $26.5M | 2.4% | +15% | — |
| 22 |  $IONQPUT | IonQ, Inc. | $25.9M | — | -8% | 30.2 |
| 23 |  $AMLX | Amylyx Pharmaceuticals, Inc. | $23.0M | 2.1% | -16% | 8.7 |
| 24 |  $AMTM | Amentum Holdings, Inc. | $22.7M | 2.1% | +42% | 64 |
| 25 |  $TGTX | TG THERAPEUTICS, INC. | $21.4M | 2.0% | -34% | 69.3 |
| 26 |  $PHAT | Phathom Pharmaceuticals, Inc. | $20.1M | 1.9% | +0% | 40.9 |
| 27 |  $U | Unity Software Inc. | $17.6M | 1.6% | NEW | 38.9 |
| 28 |  $WAL | WESTERN ALLIANCE BANCORPORATION | $16.4M | 1.5% | -11% | 67.5 |
| 29 |  $IAG | IAMGOLD CORP | $16.0M | 1.5% | -4% | 33.1 |
| 30 |  $ELV | Elevance Health, Inc. | $15.5M | 1.4% | +0% | 59 |
| 31 |  $TRAX | First Tracks Biotherapeutics, Inc. | $15.1M | 1.4% | NEW | — |
| 32 |  $KNOP | KNOT Offshore Partners LP | $15.0M | 1.4% | +2% | 43.3 |
| 33 | $QURECALL | uniQure N.V. | $14.6M | — | -75% | — |
| 34 |  $SRPT | Sarepta Therapeutics, Inc. | $14.1M | 1.3% | +4% | 47.3 |
| 35 |  $UNH | UNITEDHEALTH GROUP INC | $13.3M | 1.2% | +0% | 62.7 |
| 36 |  $SE | Sea Ltd | $12.9M | 1.2% | NEW | — |
| 37 |  $GOOG | Alphabet Inc. | $12.5M | 1.1% | -3% | 78.2 |
| 38 |  $ZVRA | ZEVRA THERAPEUTICS, INC. | $12.3M | 1.1% | -12% | 72.8 |
| 39 |  $GPC | GENUINE PARTS CO | $11.9M | 1.1% | -4% | 52.7 |
| 40 |  $ARIS | Aris Mining Corp | $11.5M | 1.1% | -4% | — |
| 41 |  $IFRX | InflaRx N.V. | $11.3M | 1.0% | +53% | — |
| 42 |  $CPNG | Coupang, Inc. | $11.3M | 1.0% | +7% | 50.6 |
| 43 |  $MRNAPUT | Moderna, Inc. | $10.9M | — | +0% | 21.2 |
| 44 |  $GXO | GXO Logistics, Inc. | $10.9M | 1.0% | -57% | 61.2 |
| 45 |  $HRMY | Harmony Biosciences Holdings, Inc. | $10.7M | 1.0% | NEW | 71.4 |
| 46 | $ALNY | ALNYLAM PHARMACEUTICALS, INC. | $10.5M | 1.0% | +67% | 71.4 |
| 47 |  $NU | Nu Holdings Ltd. | $10.0M | 0.9% | NEW | — |
| 48 |  $HHH | Howard Hughes Holdings Inc. | $10.0M | 0.9% | +294% | 70.9 |
| 49 |  $ASTH | Astrana Health, Inc. | $9.7M | 0.9% | -70% | 60.7 |
| 50 |  $ENVA | Enova International, Inc. | $9.6M | 0.9% | +0% | 69.9 |
| 51 |  $SDRL | SEADRILL Ltd | $9.1M | 0.8% | -4% | — |
| 52 |  $LEN | LENNAR CORP /NEW/ | $9.0M | 0.8% | +1900% | 47.2 |
| 53 | $LENPUT | LENNAR CORP /NEW/ | $9.0M | — | -33% | 47.2 |
| 54 |  $B | BARRICK MINING CORP | $8.9M | 0.8% | -40% | 69.6 |
| 55 |  $LXEO | Lexeo Therapeutics, Inc. | $8.7M | 0.8% | +56% | — |
| 56 |  $VTOL | Bristow Group Inc. | $8.5M | 0.8% | +10% | 51.3 |
| 57 |  $ICLR | ICON PLC | $8.3M | 0.8% | -23% | — |
| 58 |  $BLDR | Builders FirstSource, Inc. | $8.1M | 0.7% | +13% | 45.9 |
| 59 |  $STTK | Shattuck Labs, Inc. | $8.0M | 0.7% | +45% | — |
| 60 |  $HIMSPUT | Hims & Hers Health, Inc. | $7.6M | — | +0% | 53.4 |
| 61 |  $ATEX | Anterix Inc. | $6.8M | 0.6% | +43% | 61.4 |
| 62 |  $RNAC | Cartesian Therapeutics, Inc. | $6.8M | 0.6% | +97% | 8 |
| 63 |  $NE | Noble Corp plc | $6.5M | 0.6% | +17% | — |
| 64 |  $GOSS | Gossamer Bio, Inc. | $6.5M | 0.6% | +684% | 8.2 |
| 65 |  $ALEC | Alector, Inc. | $6.4M | 0.6% | +0% | 10.9 |
| 66 |  $DDI | DoubleDown Interactive Co., Ltd. | $6.3M | 0.6% | +7% | — |
| 67 |  $AIV | APARTMENT INVESTMENT & MANAGEMENT CO | $6.2M | 0.6% | +45% | 53.9 |
| 68 |  $CDLX | Cardlytics, Inc. | $5.9M | 0.5% | +32% | 19.4 |
| 69 |  $MCO | MOODYS CORP /DE/ | $5.0M | 0.5% | +0% | 79.1 |
| 70 |  $SPGI | S&P Global Inc. | $4.9M | 0.5% | +0% | 76.1 |
| 71 |  $ERII | Energy Recovery, Inc. | $4.8M | 0.4% | -4% | 58.5 |
| 72 |  $AMZN | AMAZON COM INC | $4.5M | 0.4% | -28% | 68.7 |
| 73 |  $BNED | Barnes & Noble Education, Inc. | $4.4M | 0.4% | -8% | 52.2 |
| 74 |  $RNA.R1599901 | Avidity Biosciences, Inc. | $4.0M | 0.4% | +0% | — |
| 75 |  $WW | WW INTERNATIONAL, INC. | $3.9M | 0.4% | +61% | 27.4 |
| 76 | — | SPACE ASSET ACQUISITION CORP - USD CL A ORD SHS | $3.8M | 0.3% | +0% | — |
| 77 |  $PURR | Hyperliquid Strategies Inc | $3.8M | 0.3% | -44% | 41.5 |
| 78 |  $MREO | Mereo BioPharma Group plc | $3.7M | 0.3% | -2% | — |
| 79 |  $INSMPUT | INSMED Inc | $3.7M | — | -42% | 39.4 |
| 80 |  $MICC | Magnum Ice Cream Co N.V. | $3.5M | 0.3% | NEW | — |
| 81 |  $INSE | Inspired Entertainment, Inc. | $3.5M | 0.3% | -60% | 33.3 |
| 82 |  $KYMRPUT | Kymera Therapeutics, Inc. | $3.4M | — | NEW | 28.4 |
| 83 |  $SVM | SILVERCORP METALS INC | $3.4M | 0.3% | -18% | — |
| 84 |  $VKTXCALL | Viking Therapeutics, Inc. | $3.1M | — | +33% | — |
| 85 |  $ALDX | Aldeyra Therapeutics, Inc. | $3.1M | 0.3% | -3% | — |
| 86 |  $CNTB | Connect Biopharma Holdings Ltd | $3.1M | 0.3% | +43% | — |
| 87 |  $PAAS | PAN AMERICAN SILVER CORP | $3.0M | 0.3% | -33% | — |
| 88 |  $HYLN | Hyliion Holdings Corp. | $3.0M | 0.3% | -21% | 31.1 |
| 89 |  $IOVAPUT | IOVANCE BIOTHERAPEUTICS, INC. | $2.7M | — | +0% | 36.8 |
| 90 |  $NVGS | Navigator Holdings Ltd. | $2.6M | 0.2% | -25% | — |
| 91 |  $PRQR | ProQR Therapeutics N.V. | $2.6M | 0.2% | NEW | — |
| 92 |  $LAFA | LaFayette Acquisition Corp. | $2.5M | 0.2% | +0% | — |
| 93 |  $COINPUT | Coinbase Global, Inc. | $2.5M | — | +0% | 44.8 |
| 94 | — | ACP HOLDINGS ACQUISITION COR - CL A | $2.5M | 0.2% | NEW | — |
| 95 |  $NVOPUT | NOVO NORDISK A S | $2.4M | — | -67% | — |
| 96 |  $IMUX | IMMUNIC, INC. | $2.3M | 0.2% | -94% | — |
| 97 |  $MSTRPUT | Strategy Inc | $2.2M | — | -62% | 17.9 |
| 98 |  $IVVD | Invivyd, Inc. | $2.2M | 0.2% | -1% | 29.7 |
| 99 | $INSM | INSMED Inc | $2.1M | 0.2% | NEW | 39.4 |
| 100 |  $OCTV | Octave Intelligence plc | $2.0M | 0.2% | NEW | — |
| 101 |  $CHEC | Chenghe Acquisition III Co. | $2.0M | 0.2% | +0% | — |
| 102 | — | ARCHIMEDES TECH SPAC PTNRS I - ORD SHS | $2.0M | 0.2% | +0% | — |
| 103 | — | FG IMPERII ACQUISITION CORP - ORD SHS CL A | $2.0M | 0.2% | +0% | — |
| 104 | — | LEGATO MERGER CORP IV - ORD SHS | $2.0M | 0.2% | +0% | — |
| 105 |  $PANL | Pangaea Logistics Solutions Ltd. | $1.9M | 0.2% | -3% | — |
| 106 | $COIN | Coinbase Global, Inc. | $1.9M | 0.2% | NEW | 44.8 |
| 107 |  $AMRZ | Amrize Ltd | $1.9M | 0.2% | +0% | — |
| 108 |  $HDSN | HUDSON TECHNOLOGIES INC /NY | $1.9M | 0.2% | +0% | 25.4 |
| 109 |  $MSLE | Satellos Bioscience Inc. | $1.8M | 0.2% | +0% | — |
| 110 | $AMLXCALL | Amylyx Pharmaceuticals, Inc. | $1.7M | — | +0% | 8.7 |
| 111 | — | BRIDGEBIO PHARMA INC - NOTE 1.750% 3/0 | $1.7M | 0.1% | +0% | — |
| 112 |  $RAREPUT | Ultragenyx Pharmaceutical Inc. | $1.7M | — | NEW | 34.2 |
| 113 |  $BLUW | Blue Water Acquisition Corp. III | $1.5M | 0.1% | +0% | — |
| 114 |  $MAIA | MAIA Biotechnology, Inc. | $1.5M | 0.1% | +0% | — |
| 115 |  $EVAC | EQV Ventures Acquisition Corp. II | $1.5M | 0.1% | +0% | — |
| 116 |  $HEPS | D-MARKET Electronic Services & Trading | $1.5M | 0.1% | NEW | — |
| 117 |  $PYXS | Pyxis Oncology, Inc. | $1.4M | 0.1% | -49% | 16 |
| 118 |  $TMDXPUT | TransMedics Group, Inc. | $1.3M | — | +0% | 67.2 |
| 119 | — | WILLOW LANE ACQUISITION CRP - USD CL A ORD SHS | $1.3M | 0.1% | NEW | — |
| 120 |  $PMN | ProMIS Neurosciences Inc. | $1.3M | 0.1% | +2% | — |
| 121 |  $LWAC | LightWave Acquisition Corp. | $1.0M | 0.1% | +0% | — |
| 122 |  $INAB | IN8BIO, INC. | $1.0M | 0.1% | +0% | — |
| 123 | $CDLX | Cardlytics, Inc. | $898,000 | 0.1% | NEW | 19.4 |
| 124 |  $OYSE | Oyster Enterprises II Acquisition Corp | $771,750 | 0.1% | +0% | — |
| 125 |  $CAE | CAE INC | $626,500 | 0.1% | +0% | — |
| 126 |  $GPK | GRAPHIC PACKAGING HOLDING CO | $605,894 | 0.1% | -89% | 49 |
| 127 |  $GUTS | FRACTYL HEALTH, INC. | $601,134 | 0.1% | -89% | 10 |
| 128 |  $MODD | Modular Medical, Inc. | $585,000 | 0.1% | +4% | — |
| 129 |  $CRESY | CRESUD INC | $560,500 | 0.1% | -79% | — |
| 130 | $HRMYPUT | Harmony Biosciences Holdings, Inc. | $535,227 | — | +0% | 71.4 |
| 131 |  $JATT | JATT II Acquisition Corp. | $480,119 | 0.0% | NEW | — |
| 132 |  $ORIQ | Origin Investment Corp I | $309,300 | 0.0% | +0% | — |
| 133 |  $OPTU | Optimum Communications, Inc. | $294,507 | 0.0% | +0% | 32.7 |
| 134 | $MSTR | Strategy Inc | $165,167 | 0.0% | NEW | 17.9 |
| 135 | — | SPACE ASSET ACQUISITION CORP - *W EXP 03/31/203 | $112,499 | 0.0% | +0% | — |
| 136 |  $CTMX | CytomX Therapeutics, Inc. | $75,000 | 0.0% | -95% | 8.7 |
| 137 | — | GCT SEMICONDUCTOR HLDG INC - *W EXP 03/01/202 | $62,329 | 0.0% | -78% | — |
| 138 | — | ACP HOLDINGS ACQUISITION COR - *W EXP 03/30/203 | $37,500 | 0.0% | NEW | — |
| 139 | — | ARCHIMEDES TECH SPAC PTNRS I - *W EXP 01/23/203 | $37,500 | 0.0% | +0% | — |
| 140 | $BLUW | Blue Water Acquisition Corp. III | $28,500 | 0.0% | +0% | — |
| 141 | — | WILLOW LANE ACQUISITION CRP - *W EXP 12/31/203 | $27,813 | 0.0% | NEW | — |
| 142 | — | LEGATO MERGER CORP IV - *W EXP 99/99/999 | $27,727 | 0.0% | +0% | — |
| 143 | $LAFA | LaFayette Acquisition Corp. | $25,000 | 0.0% | +0% | — |
| 144 | — | FG IMPERII ACQUISITION CORP - *W EXP 10/14/203 | $24,980 | 0.0% | +0% | — |
| 145 | $CHEC | Chenghe Acquisition III Co. | $20,500 | 0.0% | +0% | — |
| 146 | $EVAC | EQV Ventures Acquisition Corp. II | $19,875 | 0.0% | +0% | — |
| 147 | $LWAC | LightWave Acquisition Corp. | $15,495 | 0.0% | +0% | — |
| 148 | — | BOREALIS FOODS INC - *W EXP 02/07/202 | $9,400 | 0.0% | +0% | — |
| 149 | $OYSE | Oyster Enterprises II Acquisition Corp | $8,258 | 0.0% | +0% | — |
| 150 |  $ECX | ECARX Holdings Inc. | $5,000 | 0.0% | +0% | — |
New Positions (21)
$ABBVPUT AbbVie Inc.$61.7M$U Unity Software Inc.$17.6M$TRAX First Tracks Biotherapeutics, Inc.$15.1M$SE Sea Ltd$12.9M$HRMY Harmony Biosciences Holdings, Inc.$10.7M$NU Nu Holdings Ltd.$10.0M$MICC Magnum Ice Cream Co N.V.$3.5M$KYMRPUT Kymera Therapeutics, Inc.$3.4M$PRQR ProQR Therapeutics N.V.$2.6M$INSM INSMED Inc$2.1M$OCTV Octave Intelligence plc$2.0M$COIN Coinbase Global, Inc.$1.9M$RAREPUT Ultragenyx Pharmaceutical Inc.$1.7MExited Positions (103)
$TSLAPUT Tesla, Inc.$LLY ELI LILLY & Co
$FOLD AMICUS THERAPEUTICS, INC.
$APLS Apellis Pharmaceuticals, Inc.
$CCOICALL COGENT COMMUNICATIONS HOLDINGS, INC.
$BKNG Booking Holdings Inc.$CCOI COGENT COMMUNICATIONS HOLDINGS, INC.
$GSAT Globalstar, Inc.
$FRNM Freenome, Inc.
$RVMDPUT Revolution Medicines, Inc.$VKTX Viking Therapeutics, Inc.
$TBPH Theravance Biopharma, Inc.
$CZR Caesars Entertainment, Inc.
$LULUPUT lululemon athletica inc.
$ABEO ABEONA THERAPEUTICS INC.Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for 683 Capital Management, LLC including:
Track 683 Capital Management, LLC's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for 683 Capital Management, LLC and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: 683 Capital Management, LLC
13F Pro is an AI hedge fund tracker and stock research platform. For 683 Capital Management, LLC (SEC CIK: 1404574), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in 683 Capital Management, LLC's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.